首页> 外文期刊>Parasitology Research >Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis
【24h】

Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis

机译:rK39免疫色谱法和冷冻干燥直接凝集试验在诊断输入性内脏利什曼病中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Visceral leishmaniasis (VL) is one of the neglected tropical diseases that require a global policy for integrated control programs. The disease is fatal if untreated, affects ∼500,000 persons/year, and is most prevalent in poor countries. Treatment is expensive and carries a risk of toxicity. Therefore, sensitive and specific diagnosis of VL is crucial to avoid under- or overdiagnosis. Selecting an appropriate serological diagnostic test is an issue of controversy and depends on geographic location. The study aimed to evaluate the performance of two serological techniques: recombinant antigen K39 (rK39)-immunochromatographic (IC) lateral flow assay (InBios, USA) that uses a recombinant Leishmania antigen K39 and the specific IgG detection by direct agglutination test (DAT, for the diagnosis of imported VL in non-endemic region (Saudi Arabia). The diagnostic accuracy of the two assays was assessed using bone marrow aspiration, direct microscopic examination, and culture on NNN agar as the “gold standard”. The bone marrow specimens from Indian, Sudanese, and Bengali patients (n = 98) with suspected VL features were cultured. Thirty-five specimens were positive (36%). The sensitivity and specificity of rK39-IC test were 89% (95% CI 78–99) and 92% (95% CI 85–99), respectively. DAT (with cutoff ≥1:1,600) showed comparable results (sensitivity 94%; 95% CI 87–101 and specificity 95%; 95% CI 90–100). To conclude, the performance of rK39-IC test and DAT is comparable. Both tests are moderately sensitive and specific and could be used to facilitate the global drive to eliminate this disease. The rK39-IC test is a rapid, easy-to-perform test and can be used as a point-of-care diagnostic method.
机译:内脏利什曼病(VL)是被忽视的热带病之一,需要综合控制计划的全球政策。如果不加以治疗,该病将致命,每年影响约500,000人,在贫穷国家中最普遍。治疗昂贵并且具有毒性的风险。因此,VL的敏感和特异性诊断对于避免诊断不足或过度诊断至关重要。选择合适的血清学诊断测试是一个有争议的问题,并且取决于地理位置。该研究旨在评估两种血清学技术的性能:使用重组利什曼原虫抗原K39的重组抗原K39(rK39)-免疫层析(IC)横向流动测定法(InBios,美国)和通过直接凝集试验(DAT,用于非传染病地区(沙特阿拉伯)进口VL的诊断,以骨髓穿刺,直接显微镜检查和在NNN琼脂上培养作为“金标准”,评估了这两种检测方法的诊断准确性。来自印度,苏丹和孟加拉的疑似VL特征患者(n = 98)进行了培养,其中35例标本为阳性(36%),rK39-IC检测的敏感性和特异性为89%(95%CI 78-99)。 )和92%(95%CI 85-99); DAT(截止值≥1:1,600)显示出可比的结果(灵敏度94%; 95%CI 87-101和特异性95%; 95%CI 90-100)总之,rK39-IC测试与DAT的性能相当。高度敏感和特异,可用于促进全球消灭这种疾病的努力。 rK39-IC测试是一种快速,易于执行的测试,可以用作即时诊断方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号